clorazepate dipotassium has been researched along with methyldopa in 1 studies
Studies (clorazepate dipotassium) | Trials (clorazepate dipotassium) | Recent Studies (post-2010) (clorazepate dipotassium) | Studies (methyldopa) | Trials (methyldopa) | Recent Studies (post-2010) (methyldopa) |
---|---|---|---|---|---|
325 | 90 | 11 | 3,719 | 420 | 143 |
Protein | Taxonomy | clorazepate dipotassium (IC50) | methyldopa (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 5.228 | |
Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.176 | |
Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 2.126 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wheatley, D | 1 |
1 trial(s) available for clorazepate dipotassium and methyldopa
Article | Year |
---|---|
Psychological stress and cardiovascular diseases.
Topics: Anti-Anxiety Agents; Bendroflumethiazide; Cardiovascular Diseases; Clinical Trials as Topic; Clorazepate Dipotassium; Humans; Hypertension; Medazepam; Methyldopa; Propranolol; Stress, Psychological | 1984 |